Andries M Bergman

22PUBLICATIONS
171CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsGenome structure and regulationCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 28, 2026
A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|Jul 11, 2025
TRIM33 loss reduces androgen receptor transcriptional output and H2BK120 ubiquitination.

Nils Eickhoff, Janina Janetzko, Nuno Padrão

|Mar 05, 2025
Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.

Daniel P Petrylak, Raffaele Ratta, Nobuaki Matsubara

|Feb 11, 2025
Feasibility and efficacy of therapeutic drug monitoring of abiraterone in metastatic castration resistant prostate cancer patients.

Maud B A van der Kleij, Marinda Meertens, Stefanie L Groenland

|Dec 09, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer.

Lisa N Chesner, Fanny Polesso, Julie N Graff

Pageof 4

Frequent Collaborators

12 joint publications

Wilbert Zwart

4 joint publications

Felix Y Feng

4 joint publications

Anniek Zaalberg

3 joint publications

Amina Zoubeidi